ArticleEpidemiology and health2026
Long-term effectiveness of a primary care chronic disease management program in Korea.
Article in Epidemiology and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study evaluated the long-term effectiveness of Korea's Primary Care Chronic Disease Management Program (CDMP) on major clinical outcomes among patients with type 2 diabetes mellitus (T2DM).
methodsPatients aged ≥18 years who received outpatient care for T2DM in 2019 were identified using Korea's National Health Insurance Claims Database. Patients with a prior history of inpatient or outpatient care for ischemic heart disease (IHD) or stroke, or a history of hospitalization for diabetes before the index date were excluded. The final cohort included 1,817,682 patients, who were followed from the index date to December 31, 2023, for preventable diabetes-related hospitalization and incident IHD and stroke. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).
resultsThe study included 49,449 CDMP participants and 1,768,233 non-participants. The mean ages of the CDMP and non-CDMP groups were 62.2 years and 61.5 years, respectively. Compared with non-participants, CDMP participants had significantly lower risks of any adverse health outcome (HR, 0.87; 95% CI, 0.85 to 0.89), IHD (HR, 0.94; 95% CI, 0.91 to 0.97), stroke (HR, 0.85; 95% CI, 0.82 to 0.89), and diabetes-related hospitalization (HR, 0.73; 95% CI, 0.70 to 0.76).
conclusionsParticipation in the CDMP was associated with improved long-term health outcomes among patients with T2DM. These findings support the importance of continuous, structured, primary care-based chronic disease management and provide empirical evidence for expanding and institutionalizing the CDMP within Korea's National Health Insurance system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.